KEY FEATURES
| Full Name | Coagulation Factor XIII A1 Polypeptide |
|---|---|
| Synonym | F13-A1; FXIIIA1; Protein-glutamine gamma-glutamyltransferase A chain; Transglutaminase A chain; Coagulation factor XIII A chain |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.18-12ng/mL |
| Sensitivity | 0.07ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human F13A1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human F13A1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human F13A1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human F13A1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human F13A1. You can calculate the concentration of Human F13A1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human F13A1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.65 | 1.83 | 5.58 | 0.65 | 1.83 | 5.7 |
| Standard deviation | 0.04 | 0.09 | 0.19 | 0.04 | 0.11 | 0.27 |
| CV(%) | 5.9 | 4.66 | 3.49 | 6.54 | 5.81 | 4.67 |
RECOVERY
The recovery of Human F13A1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-102 | 96 |
| EDTA plasma (n=8) | 87-101 | 94 |
| Cell culture media (n=8) | 90-104 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human F13A1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with F13 ELISA Kits
| FGA ELISA Kit | publications with F13 and FGA |
| F13B ELISA Kit | publications with F13 and F13B |
| SERPINE1 ELISA Kit | publications with F13 and SERPINE1 |
| FGB ELISA Kit | publications with F13 and FGB |
| FGG ELISA Kit | publications with F13 and FGG |
Pathways associated with F13 ELISA Kit
| Common Pathway | Common Pathway |
| Complement And Coagulation Cascades Pathway | Complement And Coagulation Cascades Pathway |
| Formation Of Fibrin Clot (Clotting Cascade) Pathway | Formation Of Fibrin Clot (Clotting Cascade) Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
| Platelet Activation, Signaling And Aggregation Pathway | Platelet Activation, Signaling And Aggregation Pathway |
| Platelet Degranulation Pathway | Platelet Degranulation Pathway |
| Response To Elevated Platelet Cytosolic Ca2+ Pathway | Response To Elevated Platelet Cytosolic Ca2+ Pathway |
Diseases associated with F13 ELISA Kit
| Cardiovascular Diseases | publications with F13 and Cardiovascular Diseases |
| Factor XIII Deficiency | publications with F13 and Factor XIII Deficiency |
| Heart Diseases | publications with F13 and Heart Diseases |
| Neoplasms | publications with F13 and Neoplasms |
| Inflammation | publications with F13 and Inflammation |
| Factor Xiii, A Subunit, Deficiency Of | publications with F13 and Factor Xiii, A Subunit, Deficiency Of |
| Myocardial Infarction | publications with F13 and Myocardial Infarction |
| Carcinoma | publications with F13 and Carcinoma |
| Anemia | publications with F13 and Anemia |
| Neoplasm Metastasis | publications with F13 and Neoplasm Metastasis |
Organs/Tissues associated with F13 ELISA Kit
| Blood | publications with F13 and Blood |
| Heart | publications with F13 and Heart |
| Bone | publications with F13 and Bone |
| Kidney | publications with F13 and Kidney |
| Prostate | publications with F13 and Prostate |
| Lymph Node | publications with F13 and Lymph Node |
| Lung | publications with F13 and Lung |
| Adipose Tissue | publications with F13 and Adipose Tissue |
| Bone Marrow | publications with F13 and Bone Marrow |
| Brain | publications with F13 and Brain |